Metropolitan Life Insurance Company (MetLife)’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,206
| Closed | -$231K | – | 2820 |
|
|
2021
Q4 | $231K | Sell |
14,206
-3,230
| -19% | -$47.3K | ﹤0.01% | 1927 |
|
|
2021
Q3 | $265K | Hold |
17,436
| – | – | ﹤0.01% | 1876 |
|
|
2021
Q2 | $301K | Buy |
17,436
+1,081
| +7% | +$19.9K | ﹤0.01% | 1856 |
|
|
2021
Q1 | $319K | Sell |
16,355
-817
| -5% | -$16.8K | ﹤0.01% | 1711 |
|
|
2020
Q4 | $343K | Hold |
17,172
| – | – | 0.01% | 1606 |
|
|
2020
Q3 | $308K | Hold |
17,172
| – | – | 0.01% | 1522 |
|
|
2020
Q2 | $464K | Buy |
17,172
+3,134
| +22% | +$86.4K | 0.01% | 1266 |
|
|
2020
Q1 | $347K | Buy |
14,038
+413
| +3% | +$15K | 0.01% | 1269 |
|
|
2019
Q4 | $710K | Sell |
13,625
-360
| -3% | -$16.5K | 0.01% | 1119 |
|
|
2019
Q3 | $560K | Buy |
13,985
+666
| +5% | +$30.7K | 0.01% | 1216 |
|
|
2019
Q2 | $636K | Hold |
13,319
| – | – | 0.01% | 1155 |
|
|
2019
Q1 | $733K | Hold |
13,319
| – | – | 0.01% | 1062 |
|
|
2018
Q4 | $486K | Buy |
13,319
+208
| +2% | +$8.52K | 0.01% | 1208 |
|
|
2018
Q3 | $650K | Buy |
13,111
+1,922
| +17% | +$97.8K | 0.01% | 1190 |
|
|
2018
Q2 | $495K | Hold |
11,189
| – | – | 0.01% | 1318 |
|
|
2018
Q1 | $448K | Buy |
11,189
+328
| +3% | +$13K | 0.01% | 1354 |
|
|
2017
Q4 | $435K | Sell |
10,861
-8,873
| -45% | -$341K | 0.01% | 1382 |
|
|
2017
Q3 | $692K | Hold |
19,734
| – | – | ﹤0.01% | 1468 |
|
|
2017
Q2 | $286K | Hold |
19,734
| – | – | ﹤0.01% | 2109 |
|
|
2017
Q1 | $214K | Buy |
19,734
+2,864
| +17% | +$29K | ﹤0.01% | 2225 |
|
|
2016
Q4 | $205K | Hold |
16,870
| – | – | ﹤0.01% | 2341 |
|
|
2016
Q3 | $193K | Sell |
16,870
-3,022
| -15% | -$27.9K | ﹤0.01% | 2360 |
|
|
2016
Q2 | $160K | Hold |
19,892
| – | – | ﹤0.01% | 2484 |
|
|
2016
Q1 | $184K | Buy |
19,892
+2,671
| +16% | +$26.8K | ﹤0.01% | 2226 |
|
|
2015
Q4 | $254K | Hold |
17,221
| – | – | ﹤0.01% | 2075 |
|
|
2015
Q3 | $232K | Buy |
+17,221
| New | +$311K | ﹤0.01% | 2184 |
|
|
2014
Q3 | – | Sell |
-1,246
| Closed | -$20K | – | 2794 |
|
|
2014
Q2 | $20K | Sell |
1,246
-9,195
| -88% | -$166K | ﹤0.01% | 2760 |
|
|
2014
Q1 | $238K | Buy |
10,441
+2,265
| +28% | +$73.8K | ﹤0.01% | 2341 |
|
|
2013
Q4 | $225K | Buy |
+8,176
| New | +$183K | ﹤0.01% | 2384 |
|
Metropolitan Life Insurance Company (MetLife)'s ZGNX Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 14,206 shares — an estimated $231K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ZGNX in Q4 2013 and held it in 29 quarters. The position peaked at $733K in Q1 2019. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 14,206 Zogenix, Inc. shares in Q1 2022, an estimated $231K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Zogenix, Inc. in Q4 2013 and held it in 29 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Zogenix, Inc. position peaked at $733K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.